LYMPHOGEN
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Oct 2023)
What this means for you
This application is over — abandoned 02 Oct 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88813515
- Mark type
- Stylized text
- Filed
- 27 Feb 2020
- Published for opposition
- 07 Jul 2020
- Abandoned
- 02 Oct 2023
- Attorney of record
- Michael J. McCue
Goods and services
- Class 005 — Pharmaceuticals: Chemical compounds for medical and scientific use, namely, molecules that rescue the proliferation of white blood cells
Owner
- NANTCELL, INC., CULVER CITY, CA, US
- ImmunityBio, Inc., Culver City, CA, US
- ImmunityBio, Inc., Culver City, CA, US
Prosecution history
- 02 Oct 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Oct 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 14 Mar 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2023 — SOU EXTENSION 5 GRANTED
- 28 Feb 2023 — SOU EXTENSION 5 FILED
- 13 Mar 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Sept 2022 — SOU EXTENSION 4 GRANTED
- 01 Sept 2022 — SOU EXTENSION 4 FILED
- 01 Sept 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Mar 2022 — SOU EXTENSION 3 GRANTED
- 01 Mar 2022 — SOU EXTENSION 3 FILED
- 01 Mar 2022 — SOU TEAS EXTENSION RECEIVED